AHA	American Heart Association
ACC	American College of Cardiology
CKM	Cardiovascular–Kidney–Metabolic
CVDs	Cardiovascular Diseases
CKD	Chronic Kidney Disease
ESKD	End-Stage Kidney Disease
MetS	Metabolic Syndrome
HF	Heart Failure
LVEF	Left Ventricular Ejection Fraction
HFpEF	Heart Failure with Preserved Ejection Fraction
HFmrEF	Heart Failure with Mildly Reduced Ejection Fraction
HFrEF	Heart Failure with Reduced Ejection Fraction
WHO	World Health Organization
DM	Diabetes Mellitus
T1D	Type 1 Diabetes
T2D	Type 2 Diabetes
CAD	Coronary Artery Disease
DKD	Diabetic Kidney Disease
eGFR	Glomerular Filtration Rate
BMI	Body Mass Index
SDOH	Social Determinants of Health
FFAs	Free Fatty Acids
HDL	High-Density Lipoprotein
SNS	Sympathetic Nervous System
AGEs	Advanced Glycation End Products
KDIGO	Kidney Disease Improving Global Outcomes
ASCVD	Atherosclerotic Cardiovascular Disease
ADA	American Diabetes Association
UACR	Urinary Albumin-to-Creatinine Ratio
ESC	European Society of Cardiology
Lp(a)	Lipoprotein(a)
CAC	Coronary Artery Calcium
GLP-1RAs	Glucagon-Like Peptide 1 Receptor Agonists
GIP/GLP-1RA	Glucose-Dependent Insulinotropic Polypeptide/Glucagon-Like Peptide-1 Receptor Agonist
SGLT2is	Sodium-Glucose Cotransporter-2 Inhibitors
MACEs	Major Cardiovascular Events
ACEi	Angiotensin-Converting Enzyme Inhibitor
ARB	Angiotensin II Receptor Blocker
MRAs	Mineralocorticoid Receptor Antagonists
SCORE2	Systematic Coronary Risk Evaluation 2
RASS	Renin–Angiotensin–Aldosterone System
RAASi	Renin–Angiotensin–Aldosterone System Inhibitor